Ono Pharmaceutical Co Ltd
XMUN:ON4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Ono Pharmaceutical Co Ltd
XMUN:ON4
|
JP |
|
A
|
Applied Materials Inc
XMUN:AP2
|
US |
|
G
|
Gladstone Investment Corp
F:1G3
|
US |
|
Ease2pay NV
F:DOC2
|
NL |
|
Fox Corp
F:FO5
|
US |
|
D
|
Dubber Corp Ltd
OTC:DUBRF
|
AU |
|
Nanofilm Technologies International Ltd
OTC:NNFTF
|
SG |
|
Shiseido Co Ltd
F:SHD
|
JP |
|
Unilever Indonesia Tbk PT
F:UTG
|
ID |
|
H
|
Herbalife Ltd
XMUN:HOO
|
KY |
|
O
|
Oracle Corp Japan
XMUN:OCJ
|
JP |
Wall St Price Targets
ON4 Price Targets Summary
Ono Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for ON4 is 12.23 EUR with a low forecast of 9.53 EUR and a high forecast of 16.71 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ON4's stock price target?
Price Target
12.23
EUR
According to Wall Street analysts, the average 1-year price target for ON4 is 12.23 EUR with a low forecast of 9.53 EUR and a high forecast of 16.71 EUR.
What is the Revenue forecast for Ono Pharmaceutical Co Ltd?
Projected CAGR
-2%
Over the last 13 years, the compound annual growth rate for Revenue has been 10%. The projected CAGR for the next 3 years is -2%.
What is the Operating Income forecast for Ono Pharmaceutical Co Ltd?
Projected CAGR
40%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 2 years is 40%.
What is the Net Income forecast for Ono Pharmaceutical Co Ltd?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 3 years is 9%.
